Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7750
Gene Symbol: ZMYM2
ZMYM2
0.010 Biomarker group BEFREE Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses-A Population-Based and Propensity-Matched Cohort Study. 29138274 2018
Entrez Id: 7494
Gene Symbol: XBP1
XBP1
0.010 AlteredExpression group BEFREE The specific roles of PERK and XBP1 in CXCL10 and CCL2 expression were further investigated by treating photoreceptor cells with advanced glycation end products (AGE) and high glucose (HG), two of the major contributors to diabetic complications. 28065589 2017
Entrez Id: 7473
Gene Symbol: WNT3
WNT3
0.010 AlteredExpression group BEFREE Over-expression of lncRNA H19 increased positioning navigation latency in DM rats and decreased duration of space exploration. lncRNA H19 over-expression also increased hippocampal neuronal apoptosis and expression of Wnt3, β-catenin, TCF-1, Bax, caspase-8 and caspase-3. 29029394 2017
Entrez Id: 147179
Gene Symbol: WIPF2
WIPF2
0.010 GeneticVariation group BEFREE Studying the evolving roles of RBPs in diabetes is critical not only for a comprehensive understanding of diabetes pathogenesis but also to design RNA-based therapeutic approaches for diabetic complications.WIREs RNA 2018, 9:e1459. doi: 10.1002/wrna.1459 This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Processing > Splicing Regulation/Alternative Splicing Translation > Translation Regulation. 29280295 2018
Entrez Id: 7436
Gene Symbol: VLDLR
VLDLR
0.010 AlteredExpression group BEFREE We concluded that VLDLRI and VLDLRII had differential roles in regulating Wnt signaling and that decreased plasma levels of sVLDLR-N may contribute to Wnt signaling activation in diabetic complications. 27528615 2016
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.370 GeneticVariation group BEFREE The VEGF +405 genotype was not associated with diabetic complications in type 2 diabetes patients. 17121786 2007
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.370 Biomarker group BEFREE Recent studies suggest that increased expression of the cytokine vascular endothelial growth factor (VEGF) may play a role in the pathogenesis of diabetic complications. 12505748 2003
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.370 Biomarker group BEFREE Vascular endothelial growth factor (VEGF) is a potent angiogenic and vascular permeability factor and is implicated in both of these diabetes complications. 14988276 2004
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.370 Biomarker group BEFREE Thus, VEGF therapy may be useful in the treatment of diabetic complications characterized by impaired neovascularization. 15161630 2004
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.370 Biomarker group BEFREE Shared nodes across all networks reflected established pathogenic mechanisms of diabetes complications, such as elements of Janus kinase (JAK)/signal transducer and activator of transcription (STAT) and vascular endothelial growth factor receptor (VEGFR) signaling pathways. 23139354 2013
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.370 GeneticVariation group BEFREE Our results could help elucidate the role of VEGF splice variants in diabetic complications. 17961532 2008
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.370 Biomarker group CTD_human Gene expression profiling of changes induced by maternal diabetes in the embryonic heart. 26073000 2015
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.370 AlteredExpression group BEFREE Prolonged autoimmune injures in the retinal territory will triggers and maintains a low-grade chronic inflammation process, microvascular alterations, glial proliferation and subsequent fibrosis and worse, progressive apoptosis of the photoreceptor neurons.Patients with long-standing DM disturbances in retinal BRBs suffer of alterations in the enzymatic pathways of polyunsaturated fatty acids (PUFAs), increase release of free radicals and pro-inflammatory molecules and subsequently incremented levels of vascular endothelial growth factor. 31092270 2019
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.010 GeneticVariation group BEFREE Slight association between type 1 diabetes and "ff" VDR FokI genotype in patients from the Italian Lazio Region. Lack of association with diabetes complications. 16806146 2006
Entrez Id: 7352
Gene Symbol: UCP3
UCP3
0.010 GeneticVariation group BEFREE Patients who were heterozygous or homozygous for the G-866A polymorphism in the UCP2 gene or the C-55T polymorphism in the UCP3 gene had a significantly reduced prevalence of diabetic neuropathy (UCP2: odds ratio 0.44 [95% CI 0.24-0.79], P = 0.007; UCP3: 0.48 [0.25-0.92], P = 0.031), whereas there was no association with other diabetes complications. 16373902 2006
Entrez Id: 7351
Gene Symbol: UCP2
UCP2
0.010 GeneticVariation group BEFREE Patients who were heterozygous or homozygous for the G-866A polymorphism in the UCP2 gene or the C-55T polymorphism in the UCP3 gene had a significantly reduced prevalence of diabetic neuropathy (UCP2: odds ratio 0.44 [95% CI 0.24-0.79], P = 0.007; UCP3: 0.48 [0.25-0.92], P = 0.031), whereas there was no association with other diabetes complications. 16373902 2006
Entrez Id: 7350
Gene Symbol: UCP1
UCP1
0.010 GeneticVariation group BEFREE No effect of the A-3826G polymorphism in the UCP1 gene on diabetes complications was found. 16373902 2006
Entrez Id: 7299
Gene Symbol: TYR
TYR
0.010 Biomarker group BEFREE Functional compounds with antioxidant and AR inhibitory activities have been recognized as an important strategy in the prevention and treatment of diabetic complications, and the search for tyrosinase inhibitors is important for the treatment of hyperpigmentation, development of skin-whitening agents, and use as preservatives in the food industry. 29513344 2018
Entrez Id: 10628
Gene Symbol: TXNIP
TXNIP
0.010 AlteredExpression group BEFREE Thioredoxin interacting protein (TXNIP), an inhibitor of antioxidant thioredoxin (Trx), is upregulated by hyperglycemia and implicated in pathogenesis of diabetes complications. 26480949 2016
Entrez Id: 25828
Gene Symbol: TXN2
TXN2
0.010 Biomarker group BEFREE Thiol-related genes in diabetic complications: a novel protective role for endogenous thioredoxin 2. 17068286 2007
Entrez Id: 7295
Gene Symbol: TXN
TXN
0.010 AlteredExpression group BEFREE Thioredoxin interacting protein (TXNIP), an inhibitor of antioxidant thioredoxin (Trx), is upregulated by hyperglycemia and implicated in pathogenesis of diabetes complications. 26480949 2016
Entrez Id: 7442
Gene Symbol: TRPV1
TRPV1
0.010 Biomarker group BEFREE These data suggest that hypoxia is a new sensitization mechanism for TRPV1, which might be relevant to diabetes-related complications, and also for other diseases that are associated with acute hypoxia. 21376466 2011
Entrez Id: 7163
Gene Symbol: TPD52
TPD52
0.010 GeneticVariation group BEFREE Membrane glycoprotein PC-1 (also termed ENPP1) is a direct insulin receptor inhibitor, and certain polymorphisms of the ENPP1/PC-1 gene have been associated with insulin resistance, type 2 diabetes, obesity, and diabetic complications. 19656007 2009
Entrez Id: 64102
Gene Symbol: TNMD
TNMD
0.010 Biomarker group BEFREE Renoprotection From Diabetic Complications in OVE Transgenic Mice by Endothelial Cell Specific Overexpression of Metallothionein: A TEM Stereological Analysis. 27813325 2017
Entrez Id: 8743
Gene Symbol: TNFSF10
TNFSF10
0.010 Biomarker group BEFREE Moreover, since an increasing amount of data has indicated the important biological activities of the TRAIL/TRAIL receptor systems also in a completely different pathologic context such as diabetes mellitus, in the second part of this review we summarize the currently available data on the involvement of TRAIL in the ocular complications of diabetes mellitus as modulator of the inflammatory and angiogenic response in the eye. 25834817 2015